3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
3
Rhabdoid Tumor
1
Recurrence
1
Glioma
1
Diffuse Intrinsic Pontine Glioma
1
Brain Neoplasms
1
Interventions
Temozolomide
6
Radiotherapy
4
Cyclophosphamide
3
TIC10 compound
2
Specimen Handling
2
Irinotecan
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Everolimus
2
Etoposide
2
Diphtheria-Tetanus Vaccine
2
tovorafenib
1
spartalizumab
1
ribociclib
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
lorlatinib
1
larotrectinib
1
gallium maltolate
1
fimepinostat
1
etoposide phosphate
1
dostarlimab
1
dipinacoline glutamate
1
dinutuximab
1
balstilimab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
abemaciclib
1
Vaccines
1
Topotecan
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diffuse Intrinsic Pontine Glioma
×
gallium maltolate
×
1 year
×
Clear all
NCT07331064
2026-01-09
GABRIEL
Medical College of Wisconsin
Phase 1
Not yet recruiting
15 enrolled